Enovis Corp, trading under the symbol ENOV, is a dynamic company that embodies the spirit of technological innovation, providing pioneering solutions to specific industry needs. Established by a team of seasoned experts, Enovis Corp specializes in developing state-of-the-art software systems, offering high-quality services to businesses across the globe. The company's commitment to address its clients' unique challenges and deliver customized systems sets it apart, positioning itself as the go-to option for groundbreaking, out-of-the-box software solutions.
At Enovis Corp, the belief is that technology is not just an instrument but a transformational entity that drives growth, fosters efficiency, and empowers businesses to reach their full potential. The company has embodied this belief in its diverse offerings such as digital transformation, software development services, and business intelligence solutions.
With offices in several countries worldwide, Enovis Corp possesses a global perspective, an essential factor in its success. This diversified perspective enables the company to understand the unique needs of markets across regions, thus designing software solutions that address these specific needs. With a team comprised of subject matter experts and IT professionals, Enovis Corp harnesses collective experience and expertise to come up with industry-leading solutions.
Enovis Corp (ENOV) prides itself on its core values which include supreme quality, professionalism, innovation, and continuous improvement with a customer-centered approach. The company’s principle is to approach each project with a fresh perspective, reaching beyond traditional methodologies to deliver efficient and cost-effective solutions.
ENOV's growth trajectory has been predominantly upward, a testament to the effectiveness of its strategy. Its innovative solutions have continued to gain acceptance across all sectors, resulting in robust performance indicators year upon year. Despite entering a highly competitive market, Enovis Corp has carved its place, and now stands as a beacon of innovation and efficiency.
Enovis Corp's commitment to its customers does not end with the delivery of the software system; it extends into after-service, offering comprehensive training and support packages to ensure seamless usage. With its finger always on the pulse of the industry, the company stays at the forefront of emerging technologies, ensuring its clients always remain competitive.
Simply put, Enovis Corp is not just a software company. It is a catalyst, a partner, and an architect of progress that uses technology to create solutions transforming the way businesses operate. As the company continues to grow, so does its ambition - to go beyond traditional boundaries, push limits, and redefine what is possible in the world of technology.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends

Enovis Corp., a medical technology company, announced its binding offer to acquire eCential Robotics for €155 million (over $180 million USD). This acquisition will integrate eCential's modular surgical robotics platform into Enovis' ASTRA technology platform, enhancing its offerings in orthopedics, particularly in spine and knee surgeries, with future plans to expand into shoulder procedures. Enovis aims to bring a new robotic platform to market within two years, leveraging eCential's expertise, IP, and talent.
_07_03_2026_03_50_21_133108.jpg)
Enovis CORP CEO McDonald Damien acquired 13,035 shares of the company stock on September 4, 2026, at a price of $19.15 per share. This transaction increased his total holdings to 247,077 shares. The article highlights this insider purchase as a key event for investors to consider regarding the CEO's stake in Enovis CORP.
Enovis Corporation is acquiring France-based eCential Robotics for an upfront enterprise value of 155 million euros, with up to 35 million euros in milestone-based payments. This acquisition aims to enhance Enovis's surgical robotics portfolio by integrating eCential's modular robotic platform with Enovis's existing ASTRA and ARVIS systems. Despite an initial dip in Enovis's stock and a projected short-term impact on adjusted EBITDA margins, the deal is expected to strengthen Enovis's long-term position in the rapidly growing orthopedic robotics market.
Enovis is acquiring eCential Robotics for an upfront payment of 155 million euros, with an additional 35 million euros in contingent payments tied to development milestones. This acquisition aims to significantly advance Enovis's surgical robotics capabilities, particularly for orthopedic procedures. The company plans to launch a knee robot in late 2028 and a shoulder robot in 2029, leveraging eCential's proven technology and existing collaborations.

Enovis (NYSE: ENOV) has made a binding offer to acquire eCential Robotics for €155 million, with up to €35 million in milestone payments, aiming to expand its robotic surgery capabilities. The acquisition is expected to close by the end of 2026 and will integrate eCential's technology into Enovis' ASTRA ecosystem, with plans to launch new robotic platforms for total knee and shoulder procedures. While the deal is projected to cause temporary dilution in adjusted EBITDA margins and an increase in leverage, Enovis expects long-term benefits from robotics sales and reaffirmed its free cash flow targets.

Enovis Corporation (NYSE: ENOV), a medical technology company, announced its participation in the 2026 Wells Fargo Healthcare Conference. CEO Damien McDonald and CFO Ben Berry will host a fireside chat on September 8, 2026, at 1:30 p.m. ET. A live audio webcast and replay will be available on the company's investor relations website.